Trials / Not Yet Recruiting
Not Yet RecruitingNCT07412912
Optimizing Implementation of the Intensive Diabetes Prevention Program
Optimizing Implementation of the Intensive Diabetes Prevention Program in District Health Centres: A Hybrid Type 3 Study to Enhance Recruitment and Retention for Prediabetes Management
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to explore the effectiveness and implementation outcomes of the optimized Intensive Diabetes Prevention Program (IDPP) in District Health Centres. The main questions it aims to answer are: * Do the implementation strategies - patient engagement system, structured training, and reminder systems - work better than usual approaches in terms of acceptability, adoption, appropriateness, feasibility, sustainability, and implementation cost? * Do patient health outcomes - HbA1c levels, BMI, lipid profile, quality of life, perception of empowerment, and health service utilization - stay the same or get better when these improved strategies are used compared to usual approaches?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standard IDPP | Participants in the control group will receive the standard IDPP as routinely delivered by the DHCs, without additional engagement or implementation strategies. This includes up to four optional group education sessions, two annual nurse-led consultations, and up to three individual counselling sessions per year. |
| BEHAVIORAL | Optimized IDPP | The optimized IDPP maintains the one-year IDPP structure while adding pre-implementation staff training, two enhanced nurse consultations, a structured reminder and follow-up system, and sustainment strategies. |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2027-06-01
- Completion
- 2027-12-31
- First posted
- 2026-02-17
- Last updated
- 2026-02-17
Source: ClinicalTrials.gov record NCT07412912. Inclusion in this directory is not an endorsement.